X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32454) 32454
Book Review (3765) 3765
Publication (1237) 1237
Conference Proceeding (71) 71
Newsletter (63) 63
Magazine Article (55) 55
Book Chapter (24) 24
Dissertation (10) 10
Newspaper Article (9) 9
Book / eBook (4) 4
Web Resource (2) 2
Paper (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (30281) 30281
humans (29361) 29361
female (19777) 19777
middle aged (16958) 16958
antineoplastic combined chemotherapy protocols - therapeutic use (16817) 16817
male (16086) 16086
fluorouracil - administration & dosage (16082) 16082
aged (14675) 14675
oncology (14267) 14267
adult (12462) 12462
fluorouracil - therapeutic use (10875) 10875
chemotherapy (9599) 9599
fluorouracil (8693) 8693
cancer (7421) 7421
treatment outcome (6791) 6791
5-fluorouracil (5611) 5611
combined modality therapy (5007) 5007
antineoplastic combined chemotherapy protocols - adverse effects (4974) 4974
cisplatin - administration & dosage (4763) 4763
colorectal neoplasms - drug therapy (4721) 4721
fluorouracil - adverse effects (4292) 4292
neoplasm staging (4170) 4170
breast neoplasms - drug therapy (4092) 4092
leucovorin - administration & dosage (3939) 3939
chemotherapy, adjuvant (3833) 3833
prognosis (3805) 3805
aged, 80 and over (3768) 3768
colorectal cancer (3761) 3761
animals (3608) 3608
deoxycytidine - analogs & derivatives (3606) 3606
antineoplastic agents - therapeutic use (3588) 3588
survival rate (3504) 3504
adenocarcinoma - drug therapy (3475) 3475
drug administration schedule (3378) 3378
surgery (3312) 3312
disease-free survival (3294) 3294
capecitabine (3251) 3251
carcinoma (3237) 3237
colorectal neoplasms - pathology (3090) 3090
therapy (3088) 3088
antimetabolites, antineoplastic - therapeutic use (3042) 3042
fluorouracil - analogs & derivatives (3038) 3038
leucovorin (3014) 3014
retrospective studies (2975) 2975
care and treatment (2882) 2882
antineoplastic combined chemotherapy protocols - administration & dosage (2881) 2881
survival analysis (2850) 2850
pharmacology & pharmacy (2811) 2811
follow-up studies (2713) 2713
neoplasm metastasis (2712) 2712
oxaliplatin (2689) 2689
organoplatinum compounds - administration & dosage (2599) 2599
radiotherapy (2595) 2595
cisplatin (2561) 2561
stomach neoplasms - drug therapy (2558) 2558
survival (2544) 2544
camptothecin - analogs & derivatives (2532) 2532
abridged index medicus (2481) 2481
cyclophosphamide - administration & dosage (2423) 2423
deoxycytidine - administration & dosage (2367) 2367
medicine & public health (2351) 2351
liver neoplasms - secondary (2248) 2248
liver neoplasms - drug therapy (2232) 2232
mice (2181) 2181
carcinoma, squamous cell - drug therapy (2179) 2179
trial (2139) 2139
metastasis (2117) 2117
colonic neoplasms - drug therapy (2109) 2109
research (2087) 2087
time factors (2041) 2041
methotrexate - administration & dosage (1953) 1953
prospective studies (1953) 1953
fluorouracil - pharmacology (1917) 1917
analysis (1906) 1906
breast neoplasms - pathology (1868) 1868
doxorubicin - administration & dosage (1836) 1836
breast cancer (1795) 1795
camptothecin - administration & dosage (1789) 1789
antimetabolites, antineoplastic - administration & dosage (1781) 1781
irinotecan (1737) 1737
leucovorin - therapeutic use (1722) 1722
lymphatic metastasis (1687) 1687
bevacizumab (1590) 1590
clinical trials as topic (1561) 1561
neoadjuvant therapy (1561) 1561
drug therapy, combination (1559) 1559
tumors (1552) 1552
dose-response relationship, drug (1540) 1540
adenocarcinoma - pathology (1523) 1523
infusions, intravenous (1514) 1514
antineoplastic agents - administration & dosage (1467) 1467
health aspects (1452) 1452
deoxycytidine - therapeutic use (1441) 1441
drug therapy (1416) 1416
rectal neoplasms - drug therapy (1416) 1416
stomach neoplasms - pathology (1410) 1410
colorectal-cancer (1404) 1404
1st-line treatment (1402) 1402
chemoradiotherapy (1380) 1380
randomized-trial (1376) 1376
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27696) 27696
Japanese (2284) 2284
German (639) 639
French (581) 581
Chinese (442) 442
Russian (344) 344
Italian (204) 204
Spanish (120) 120
Polish (64) 64
Hungarian (35) 35
Korean (26) 26
Danish (20) 20
Portuguese (20) 20
Dutch (19) 19
Czech (18) 18
Hebrew (18) 18
Norwegian (16) 16
Ukrainian (10) 10
Bulgarian (9) 9
Romanian (9) 9
Slovak (8) 8
Swedish (7) 7
Serbian (5) 5
Croatian (4) 4
Lithuanian (3) 3
Finnish (2) 2
Afrikaans (1) 1
Icelandic (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2278 - 2284
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2005, Volume 16, Issue 5, pp. 762 - 766
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 38 - 47
Summary Background Neoadjuvant chemotherapy for unresectable colorectal liver metastases can downsize tumours for curative resection. We assessed the... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | BEVACIZUMAB | OXALIPLATIN | FLUOROURACIL | HEPATIC RESECTION | CANCER | CARCINOMA | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Tomography, Spiral Computed | Liver Neoplasms - chemistry | Hepatectomy | Antibodies, Monoclonal, Humanized | Fluorouracil - therapeutic use | Austria | Leucovorin - adverse effects | Fluorouracil - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Female | Leucovorin - therapeutic use | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Cetuximab | Liver Neoplasms - secondary | Odds Ratio | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Camptothecin - therapeutic use | Liver Neoplasms - genetics | Risk Assessment | Liver Neoplasms - drug therapy | Linear Models | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Magnetic Resonance Imaging | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Aged | Mutation | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Germany | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1065 - 1075
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 07/2014, Volume 12, Issue 7, pp. 1028 - 1059
The NCCN Guidelines for Colon Cancer address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance,... 
PHASE-III TRIAL | GROWTH-FACTOR RECEPTOR | UNRESECTABLE LIVER METASTASES | BEVACIZUMAB-CONTAINING ARMS | ONCOLOGY | HIGH-DOSE LEUCOVORIN | POSTPROGRESSION SURVIVAL-TIME | 1ST-LINE COMBINATION CHEMOTHERAPY | KRAS WILD-TYPE | CAPECITABINE PLUS OXALIPLATIN | METASTATIC COLORECTAL-CANCER | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Colonic Neoplasms - drug therapy | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Bevacizumab | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Deoxycytidine - adverse effects | Leucovorin - therapeutic use | Cetuximab | Liver Neoplasms - secondary | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Camptothecin - therapeutic use | Fluorouracil - analogs & derivatives | Membrane Proteins - genetics | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | GTP Phosphohydrolases - genetics | Proto-Oncogene Proteins B-raf - genetics | Colonic Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 01/2015, Volume 26, Issue 1, pp. 141 - 148
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1355 - 1369
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2004, Volume 15, Issue 3, pp. 460 - 466
Journal Article